Wang YJ - Search Results

1

Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.

Jiang L, Wang YJ, Zhao J, Uehara M, Hou Q, Kasinath V, Ichimura T, Banouni N, Dai L, Li X, Greiner DL, Shultz LD, Zhang X, Sun ZJ, Curtin I, Vangos NE, Yeoh ZC, Geffken EA, Seo HS, Liu ZX, Heffron GJ, Shah K, Dhe-Paganon S, Abdi R. Jiang L, et al. Among authors: wang yj. Cell. 2020 Nov 25;183(5):1219-1233.e18. doi: 10.1016/j.cell.2020.10.045. Cell. 2020. PMID: 33242418 Free PMC article.

2

In situ vaccination caused by diverse irradiation-driven cell death programs.

Wang Y, Li Y, Yang Y, Swift M, Zhang Z, Wu S, Sun Y, Yang K. Wang Y, et al. Theranostics. 2024 Jan 12;14(3):1147-1167. doi: 10.7150/thno.86004. eCollection 2024. Theranostics. 2024. PMID: 38323315 Free PMC article. Review.

3

Colorectal cancer prevention: Immune modulation taking the stage.

Fletcher R, Wang YJ, Schoen RE, Finn OJ, Yu J, Zhang L. Fletcher R, et al. Among authors: wang yj. Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):138-148. doi: 10.1016/j.bbcan.2017.12.002. Epub 2018 Jan 31. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29391185 Free PMC article. Review.

4

BET Inhibitors Potentiate Chemotherapy and Killing of SPOP-Mutant Colon Cancer Cells via Induction of DR5.

Tan X, Tong J, Wang YJ, Fletcher R, Schoen RE, Yu J, Shen L, Zhang L. Tan X, et al. Among authors: wang yj. Cancer Res. 2019 Mar 15;79(6):1191-1203. doi: 10.1158/0008-5472.CAN-18-3223. Epub 2019 Jan 23. Cancer Res. 2019. PMID: 30674532 Free PMC article.

5

Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.

Sun M, Ji X, Xie M, Chen X, Zhang B, Luo X, Feng Y, Liu D, Wang Y, Li Y, Liu B, Xia L, Huang W. Sun M, et al. Front Immunol. 2022 Dec 5;13:999084. doi: 10.3389/fimmu.2022.999084. eCollection 2022. Front Immunol. 2022. PMID: 36544770 Free PMC article.

6

Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunity.

Hu Y, Sun Y, Liao Z, An D, Liu X, Yang X, Tian Y, Deng S, Meng J, Wang Y, Li J, Deng Y, Zhou Z, Chen Q, Ye Y, Wei W, Wu B, Lovell JF, Jin H, Huang F, Wan C, Yang K. Hu Y, et al. Mol Ther. 2024 Feb 7;32(2):411-425. doi: 10.1016/j.ymthe.2023.12.012. Epub 2023 Dec 13. Mol Ther. 2024. PMID: 38098229

7

Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment.

Deng Y, Chen Q, Yang X, Sun Y, Zhang B, Wei W, Deng S, Meng J, Hu Y, Wang Y, Zhang Z, Wen L, Huang F, Wan C, Yang K. Deng Y, et al. Theranostics. 2024 Jan 20;14(3):1224-1240. doi: 10.7150/thno.91119. eCollection 2024. Theranostics. 2024. PMID: 38323313 Free PMC article.

8

Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.

Knickelbein K, Tong J, Chen D, Wang YJ, Misale S, Bardelli A, Yu J, Zhang L. Knickelbein K, et al. Among authors: wang yj. Oncogene. 2018 Aug;37(33):4599-4610. doi: 10.1038/s41388-018-0289-x. Epub 2018 May 14. Oncogene. 2018. PMID: 29755130 Free PMC article.

9

Immunogenic effects of chemotherapy-induced tumor cell death.

Wang YJ, Fletcher R, Yu J, Zhang L. Wang YJ, et al. Genes Dis. 2018 May 17;5(3):194-203. doi: 10.1016/j.gendis.2018.05.003. eCollection 2018 Sep. Genes Dis. 2018. PMID: 30320184 Free PMC article. Review.

10

FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC.

Chen X, Chen J, Feng W, Huang W, Wang G, Sun M, Luo X, Wang Y, Nie Y, Fan D, Wu K, Xia L. Chen X, et al. Theranostics. 2023 Feb 22;13(4):1401-1418. doi: 10.7150/thno.82269. eCollection 2023. Theranostics. 2023. PMID: 36923538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,490 results

Search Page